Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 18, 2004

View Archived Issues

Antiangiogenic small molecule inhibits VEGF production in tumors in vivo

Turmeric extract prevents arthritis in rat model

Pharmacokinetic profile of novel bone resorption inhibitor

Nucleotide-bisphosphonate conjugates reduce metastatic bone tumor burden in mice

Novel vasopressin V1a receptor antagonists and their use in dysmenorrhea

New analgesic vanilloid VR1 antagonists discovered at Merck

Antagonists of denatured collagen type IV and their use as antiangiogenic agents

Novel PPAR agonists and their use described by Pfizer researchers

Neurogen presents novel GABA-A receptor modulators

New benzofurans acting as 5-HT reuptake inhibitors and 5-HT receptor ligands

New indole-containing oxazolidinone antibacterial agents identified at Pfizer

Highlights from the 4th Annual Biotech In Europe Investor Forum now available at LifeSciChannel.com

Anecortave acetate study results

R&D highlights from the 4th Annual Biotech In Europe Investor Forum: BioTie Therapies

ArQule discovers oral B-RAF kinase inhibitors for oncology

CuraGen advances CR-011 for metastatic melanoma

Cerovive phase III trials to continue

Visudyne VIO study recommended to continue

IND submission for Syrrx-designed DPP IV inhibitor for diabetes

Enrollment opens in phase II study of MX-3253

JuvImmune platform to be tested in PuntaToro virus infection model

Patients receive HGS-ETR1 in new cancer studies

AGIX-4207 discontinued for rheumatoid arthritis after disappointing results

Pivotal PolyHeme study cleared to continue

R&D highlights from the 4th Annual Biotech In Europe Investor Forum: BioXell

Vantas approved for advanced prostate cancer

Government funding for Elusys' development of anthrax antibody treatment

Abarelix demonstrates safety and efficacy in clinical trials

New data on the antimicrobial activity and pharmacokinetics of tigecycline

HepeX-C reduces viral levels in patients with chronic HCV infection

Bone turnover has no effect on the benefits of teriparatide in women with osteoporosis

Update on the pharmacokinetic profile of a transdermal PTH formulation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...